Resultados de búsqueda - David Zahrieh

Limitar resultados
  1. 1
    Ferroportin1 is required for normal iron cycling in zebrafish

    Ferroportin1 is required for normal iron cycling in zebrafish por Paula G. Fraenkel, David Traver, Adriana Donovan, David Zahrieh, Leonard I. Zon

    Publicado 2005
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  2. 2
    Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells

    Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells por Güllü Görgün, Tobias A.W. Holderried, David Zahrieh, Donna Neuberg, John G. Gribben

    Publicado 2005
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  3. 3
    Comparison of frozen and RNALater solid tissue storage methods for use in RNA expression microarrays

    Comparison of frozen and RNALater solid tissue storage methods for use in RNA expression microarrays por George L. Mutter, David Zahrieh, Chunmei Liu, Donna Neuberg, David Finkelstein, Heather E Baker, Janet A. Warrington

    Publicado 2004
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  4. 4
    X-inactivation–based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis

    X-inactivation–based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a sub... por Ross L. Levine, Claude Bélisle, Martha Wadleigh, David Zahrieh, Stephanie J. Lee, Pierre Chagnon, D. Gary Gilliland, Lambert Busque

    Publicado 2006
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  5. 5
    Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy

    Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy por Akiko Saito, David Zahrieh, Corey Cutler, Vincent T. Ho, Joseph H. Antin, Robert J. Soiffer, Edwin P. Alyea, S J Lee

    Publicado 2007
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  6. 6
    Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93

    Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93 por Olivia Pagani, Shari Gelber, E. Simoncini, Monica Castiglione‐Gertsch, K. Price, David Zahrieh, Richard D. Gelber, Alan S. Coates, Aron Goldhirsch

    Publicado 2004
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    Costs of Allogeneic Hematopoietic Cell Transplantation with High-Dose Regimens

    Costs of Allogeneic Hematopoietic Cell Transplantation with High-Dose Regimens por Akiko Saito, Corey Cutler, David Zahrieh, Robert J. Soiffer, Vincent T. Ho, Edwin P. Alyea, John Koreth, Joseph H. Antin, Stephanie J. Lee

    Publicado 2008
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  8. 8
    Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas

    Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas por Palma Dileo, Jeffrey A. Morgan, David Zahrieh, Jayesh Desai, Jeanine M. Salesi, David C. Harmon, Mikayla Quigley, Kathleen Polson, George D. Demetri, Suzanne George

    Publicado 2007
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  9. 9
    Eμ- <i>TCL1</i> mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction

    Eμ- <i>TCL1</i> mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction por Güllü Görgün, Alan G. Ramsay, Tobias A.W. Holderried, David Zahrieh, Rifca Le Dieu, Fenglong Liu, John Quackenbush, Carlo M. Croce, John G. Gribben

    Publicado 2009
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  10. 10
    Surgical Management of Advanced Gastrointestinal Stromal Tumors After Treatment With Targeted Systemic Therapy Using Kinase Inhibitors

    Surgical Management of Advanced Gastrointestinal Stromal Tumors After Treatment With Targeted Systemic Therapy Using Kinase Inhibitors por Chandrajit P. Raut, Matthew Posner, Jayesh Desai, Jeffrey A. Morgan, Suzanne George, David Zahrieh, Christopher D.�M. Fletcher, George D. Demetri, Monica M. Bertagnolli

    Publicado 2006
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  11. 11
    Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion

    Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion por Robert J. Soiffer, Edwin P. Alyea, Ephraim P. Hochberg, Catherine J. Wu, Christine Canning, Bijal Parikh, David Zahrieh, Iain J. Webb, Joseph H. Antin, Jerome Ritz

    Publicado 2002
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  12. 12
    Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

    Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation por Martha Wadleigh, Paul G. Richardson, David Zahrieh, Stephanie J. Lee, Corey Cutler, Vincent T. Ho, Edwin P. Alyea, Joseph H. Antin, Richard M. Stone, Robert J. Soiffer, Daniel J. DeAngelo

    Publicado 2003
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  13. 13
    Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial

    Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial por Stephanie J. Lee, David Zahrieh, Edward Agura, Margaret L. MacMillan, Richard T. Maziarz, Philip L. McCarthy, Vincent T. Ho, Corey Cutler, Edwin P. Alyea, Joseph H. Antin, Robert J. Soiffer

    Publicado 2004
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  14. 14
    Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy

    Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy por Marco Colleoni, Giuseppe Viale, David Zahrieh, Luca Bottiglieri, Richard D. Gelber, Paolo Veronesi, Alessandra Balduzzi, Rosalba Torrisi, Alberto Luini, Mattia Intra, Silvia Dellapasqua, A. Cardillo, R. Ghisini, G. Peruzzotti, Aron Goldhirsch

    Publicado 2007
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  15. 15
    Chemotherapy Is More Effective in Patients with Breast Cancer Not Expressing Steroid Hormone Receptors

    Chemotherapy Is More Effective in Patients with Breast Cancer Not Expressing Steroid Hormone Receptors por Marco Colleoni, Giuseppe Viale, David Zahrieh, Giancarlo Pruneri, Oreste ­Gentilini, Paolo Veronesi, Richard D. Gelber, Giuseppe Curigliano, Rosalba Torrisi, Alberto Luini, Mattia Intra, Viviana Galimberti, Giuseppe Renne, Franco Nolè, G. Peruzzotti, Aron Goldhirsch

    Publicado 2004
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  16. 16
    Randomized Trial Comparing Axillary Clearance Versus No Axillary Clearance in Older Patients With Breast Cancer: First Results of International Breast Cancer Study Group Trial 10-93

    Randomized Trial Comparing Axillary Clearance Versus No Axillary Clearance in Older Patients With Breast Cancer: First Results of International Breast Cancer Study Group Trial 10-9... por Carl‐Magnus Rudenstam, David Zahrieh, John Forbes, Diana Crivellari, Stig B. Holmberg, Piercarlo Rey, D M Dent, Ian Campbell, Jürg Bernhard, Karen N. Price, Monica Castiglione‐Gertsch, Aron Goldhirsch, Richard D. Gelber, Alan S. Coates

    Publicado 2005
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  17. 17
    Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials

    Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials por Bernhard C. Pestalozzi, David Zahrieh, Elizabeth Mallon, Barry A. Gusterson, Karen N. Price, Richard D. Gelber, Stig B. Holmberg, Jurij Lindtner, Raymond Snyder, Beat Thürlimann, Elizabeth Murray, Giuseppe Viale, Monica Castiglione‐Gertsch, Alan S. Coates, Aron Goldhirsch

    Publicado 2008
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  18. 18
    Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia

    Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia por John G. Gribben, David Zahrieh, Katherine Stephans, L Bartlett-Pandite, Edwin P. Alyea, David C. Fisher, Arnold S. Freedman, Peter Mauch, Robert Schlossman, Lecia V. Sequist, Robert J. Soiffer, Blossom Marshall, Donna Neuberg, Jerome Ritz, Lee M. Nadler

    Publicado 2005
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  19. 19
    Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)

    Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG) por Bernhard C. Pestalozzi, David Zahrieh, Karen N. Price, Stig B. Holmberg, Jurij Lindtner, John P. Collins, Diana Crivellari, Martin F. Fey, Elizabeth Murray, Olivia Pagani, Edda Simoncini, Monica Castiglione‐Gertsch, Richard D. Gelber, Alan S. Coates, Aron Goldhirsch

    Publicado 2006
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  20. 20
    Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia

    Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia por Eyal C. Attar, Daniel J. DeAngelo, Jeffrey G. Supko, Ferdinando D’Amato, David Zahrieh, Andres Sirulnik, Martha Wadleigh, Karen K. Ballen, Steve McAfee, Kenneth B. Miller, James D. Levine, Ilene Galinsky, Elizabeth Trehu, David P. Schenkein, Donna Neuberg, Richard M. Stone, Philip C. Amrein

    Publicado 2008
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: